Suppr超能文献

慢性肾脏病对减重手术后围手术期风险和死亡率的影响。

The Impact of CKD on Perioperative Risk and Mortality after Bariatric Surgery.

机构信息

Department of Surgery, New York University School of Medicine, New York, New York.

Diabetes Complications Research Centre, School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland.

出版信息

Kidney360. 2020 Dec 14;2(2):236-244. doi: 10.34067/KID.0004832020. eCollection 2021 Feb 25.

Abstract

BACKGROUND

Twenty percent of patients with CKD in the United States have a body mass index (BMI) ≥35 kg/m. Bariatric surgery reduces progression of CKD to ESKD, but the risk of perioperative complications remains a concern.

METHODS

The 24-month data spanning 2017-2018 were obtained from the Metabolic and Bariatric Surgery Quality Improvement Program (MBSAQIP) database and analyzed. Surgical complications were assessed on the basis of the length of hospital stay, mortality, reoperation, readmission, surgical site infection (SSI), and worsening of kidney function during the first 30 days after surgery.

RESULTS

The 277,948 patients who had primary bariatric procedures were 44±11.9 (mean ± SD) years old, 79.6% were women, and 71.2% were White. Mean BMI was 45.7±7.6 kg/m. Compared with patients with an eGFR≥90 ml/min per BSA, those with stage 5 CKD/ESKD were 1.91 times more likely to be readmitted within 30 days of a bariatric procedure (95% CI, 1.37 to 2.67; <0.001). Similarly, length of hospital stay beyond 2 days was 2.05-fold (95% CI, 1.64 to 2.56; <0.001) higher and risk of deep incisional SSI was 6.92-fold (95% CI, 1.62 to 29.52; =0.009) higher for those with stage 5 CKD/ESKD. Risk of early postoperative mortality increased with declining preoperative eGFR, such that patients with stage 3b CKD were 3.27 (95% CI, 1.82 to 5.89; <0.001) times more likely to die compared with those with normal kidney function. However, absolute mortality rates remained relatively low at 0.53% in those with stage 3b CKD. Furthermore, absolute mortality rates were <0.5% in those with stages 4 and 5 CKD, and these advanced CKD stages were not independently associated with an increased risk of early postoperative mortality.

CONCLUSIONS

Increased severity of kidney disease was associated with increased complications after bariatric surgery. However, even for the population with advanced CKD, the absolute rates of postoperative complications were low. The mounting evidence for bariatric surgery as a renoprotective intervention in people with and without established kidney disease suggests that bariatric surgery should be considered a safe and effective option for patients with CKD.

摘要

背景

在美国,20%的慢性肾脏病(CKD)患者的体重指数(BMI)≥35 kg/m。减重手术可降低 CKD 进展为终末期肾病(ESKD)的风险,但围手术期并发症的风险仍然令人担忧。

方法

2017 年至 2018 年期间,从代谢和减重手术质量改进计划(MBSAQIP)数据库中获取了 24 个月的数据,并进行了分析。根据住院时间、死亡率、再次手术、再入院、手术部位感染(SSI)和术后 30 天内肾功能恶化,评估手术并发症。

结果

接受主要减重手术的 277948 例患者年龄为 44±11.9(平均值±标准差)岁,79.6%为女性,71.2%为白人。平均 BMI 为 45.7±7.6 kg/m。与 eGFR≥90 ml/min/BSA 的患者相比,CKD/ESKD 5 期患者在减重手术后 30 天内再入院的可能性高 1.91 倍(95%CI,1.37 至 2.67;<0.001)。同样,住院时间超过 2 天的风险高 2.05 倍(95%CI,1.64 至 2.56;<0.001),深部切口 SSI 的风险高 6.92 倍(95%CI,1.62 至 29.52;=0.009),CKD/ESKD 5 期患者风险更高。随着术前 eGFR 的降低,术后早期死亡率的风险增加,因此,3b 期 CKD 患者死亡的可能性是肾功能正常患者的 3.27 倍(95%CI,1.82 至 5.89;<0.001)。然而,3b 期 CKD 患者的绝对死亡率仍相对较低,为 0.53%。此外,4 期和 5 期 CKD 患者的绝对死亡率均<0.5%,并且这些晚期 CKD 阶段与术后早期死亡率增加无关。

结论

肾脏疾病严重程度的增加与减重手术后并发症的增加相关。然而,即使对于晚期 CKD 患者,术后并发症的绝对发生率也较低。减重手术作为预防和治疗患有和不患有已确诊肾病患者的肾脏保护干预措施的证据不断增加,表明减重手术应被视为 CKD 患者的一种安全有效的选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验